Bank of America’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-202
Closed -$1.85K 8593
2025
Q1
$1.85K Buy
202
+124
+159% +$778 ﹤0.01% 7347
2024
Q4
$521 Sell
78
-3
-4% -$26 ﹤0.01% 7401
2024
Q3
$812 Sell
81
-928
-92% -$13.5K ﹤0.01% 7291
2024
Q2
$15.7K Buy
1,009
+293
+41% +$4.91K ﹤0.01% 6797
2024
Q1
$15.7K Sell
716
-3,018
-81% -$67K ﹤0.01% 6790
2023
Q4
$72.3K Sell
3,734
-20,534
-85% -$375K ﹤0.01% 6495
2023
Q3
$448K Buy
24,268
+24,175
+25,995% +$435K ﹤0.01% 5390
2023
Q2
$1.71K Sell
93
-471
-84% -$11.1K ﹤0.01% 7166
2023
Q1
$16.3K Buy
564
+219
+63% +$5.83K ﹤0.01% 6812
2022
Q4
$9.58K Buy
345
+285
+475% +$10.8K ﹤0.01% 6927
2022
Q3
$4K Sell
60
-34
-36% -$1.87K ﹤0.01% 7442
2022
Q2
$5K Sell
94
-251
-73% -$9.23K ﹤0.01% 7587
2022
Q1
$13K Sell
345
-1,093
-76% -$39K ﹤0.01% 7664
2021
Q4
$35K Sell
1,438
-961
-40% -$32.2K ﹤0.01% 7351
2021
Q3
$108K Sell
2,399
-3,973
-62% -$167K ﹤0.01% 6679
2021
Q2
$297K Buy
6,372
+447
+8% +$22.8K ﹤0.01% 5810
2021
Q1
$328K Buy
5,925
+2,368
+67% +$144K ﹤0.01% 5692
2020
Q4
$221K Sell
3,557
-7,958
-69% -$487K ﹤0.01% 5535
2020
Q3
$673K Buy
11,515
+1,841
+19% +$136K ﹤0.01% 4497
2020
Q2
$1.08M Buy
9,674
+1,859
+24% +$132K ﹤0.01% 4063
2020
Q1
$527K Sell
7,815
-3
-0% -$302 ﹤0.01% 4472
2019
Q4
$1.08M Buy
7,818
+254
+3% +$32.9K ﹤0.01% 4451
2019
Q3
$794K Buy
7,564
+518
+7% +$51.7K ﹤0.01% 4723
2019
Q2
$748K Buy
7,046
+530
+8% +$69.8K ﹤0.01% 4781
2019
Q1
$1.01M Buy
6,516
+2,943
+82% +$341K ﹤0.01% 4509
2018
Q4
$332K Buy
3,573
+864
+32% +$123K ﹤0.01% 5193
2018
Q3
$504K Buy
2,709
+382
+16% +$109K ﹤0.01% 4938
2018
Q2
$976K Buy
2,327
+741
+47% +$250K ﹤0.01% 4482
2018
Q1
$476K Buy
1,586
+146
+10% +$40.4K ﹤0.01% 4843
2017
Q4
$408K Buy
+1,440
New +$405K ﹤0.01% 5068

Bank of America's OPTN Position: Q2 2025 in Review

Bank of America sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 202 shares — an estimated $1.85K sold.

Bank of America first reported a position in OPTN in Q4 2017 and held it in 30 quarters. The position peaked at $1.08M in Q4 2019. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.

  • Bank of America reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
  • Bank of America sold 202 OptiNose shares in Q2 2025, an estimated $1.85K.
  • Bank of America first reported a position in OptiNose in Q4 2017 and held it in 30 quarters.
  • Bank of America's OptiNose position peaked at $1.08M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.

Based on Bank of America's 13F filing for Q2 2025, filed 14 Aug 2025.